Common Contracts
4 similar Underwriting Agreement contracts by Cascadian Therapeutics, Inc., Molecular Templates, Inc., Oncothyreon Inc., Societal CDMO, Inc.
Societal CDMO, Inc. Series A Convertible Preferred Stock, par value $0.01 per share Underwriting AgreementUnderwriting Agreement • December 13th, 2022 • Societal CDMO, Inc. • Pharmaceutical preparations
Societal CDMO, Inc., a Pennsylvania corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”), for whom RBC Capital Markets, LLC is acting as representative (the “Representative” or “you”) an aggregate of 450,000 series A convertible preferred stock, par value $0.01 per share, (the “Securities”).
6,000,000 Shares of Common Stock Molecular Templates, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • November 25th, 2019 • Molecular Templates, Inc. • Pharmaceutical preparations • New York
1,818 Shares CASCADIAN THERAPEUTICS, INC. Series E Convertible Preferred Stock UNDERWRITING AGREEMENTUnderwriting Agreement • January 24th, 2017 • Cascadian Therapeutics, Inc. • Services-commercial physical & biological research • New York
1,333 Shares ONCOTHYREON INC. Series B Convertible Preferred Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 6th, 2015 • Oncothyreon Inc. • Services-commercial physical & biological research • New York
